Journal: Annals of neurosciences

Article Title: A Novel Way of Amelioration of Amyloid Beta Induced Toxicity in Caenorhabditis elegans .

PMID/MRN: 27721583

Publication Date: 2016-Sep-02

Abstract:

With an incidence of 1 in 85 persons above the age of 60 years succumbing to the disease, Alzheimer's disease (AD), has been predicted to create havoc globally. In spite of enormous efforts and exhaustive research, no cure is in sight. Hence, it is critical to unravel the mechanism of AD development/protection and identification of a cure soon. This study is aimed at investigating the mechanism of reserpine action, which alleviates the toxicity of amyloid beta (A?) (AD-causing peptide) in Caenorhabditis elegans [1, 2]. Determination of alleviation of A? toxicity with reserpine manifested as reduction in progressive paralysis, in the background of GFP reporter driven by the promoter of the FMRFamide neuropeptide, FLP-11 (AD; P flp-11 ::GFP) and acetylcholine contribution through aldicarb (which inhibits acetylcholine esterase) treatment. The most significant protection against A? toxicity was obtained in the background of P flp-11 ::GFP. This protection had 2 components. The promoter of FLP-11 with the reporter GFP, P flp-11 ::GFP, per se gave significant protection. Further reserpine treatment provided additional alleviation. Together they could almost eliminate A? toxicity. These 2 components of A? toxicity alleviation are dependent on acetylcholine levels, as an increase in acetylcholine by aldicarb treatment reduces the protective effect. A unique way to alleviate A? toxicity is reserpine treatment in combination with P flp-11 ::GFP. Reserpine should be evaluated as a potential drug in a pilot study in AD patients. Furthermore, identification of the mechanism of Pflp-11::GFP-mediated reduction in A? toxicity is a potential pathway to develop therapeutics for AD.